Trials / Completed
CompletedNCT01288898
Multiple Dose Escalating Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP1941
A Double-blind, Placebo-controlled, Dose Escalating Study to Assess the Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of ASP1941 and to Explore the Effect of ASP1941 on Urine and Blood Glucose Levels in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 48 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study determined the safety of ASP1941 after a single and multiple once-daily doses for 10 days in healthy subjects. In addition, the Pharmacokinetics (PK) and Pharmacodynamics (PD) of ASP1941 were assessed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ASP1941 | Oral |
| DRUG | Placebo | Oral |
Timeline
- Start date
- 2007-05-01
- Primary completion
- 2008-03-01
- Completion
- 2008-03-01
- First posted
- 2011-02-03
- Last updated
- 2011-02-03
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01288898. Inclusion in this directory is not an endorsement.